Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiner Wedemeyer

Showing results (1-10 of 770) with videos related to

Pageof 77
Sort By:
Journal of Hepatology|November 14, 2009
EASL transitioning into the new decadeHeiner Wedemeyer
Transplantation|March 22, 2018
E-xchange: Hepatitis E and the Risk of Plasma Products for Organ Transplant RecipientsHeiner Wedemeyer
Journal of Hepatology|July 21, 2020
The burden of hepatitis D - defogging the epidemiological horizonHeiner Wedemeyer
Lancet (London, England)|April 4, 2015
Towards interferon-free treatment for all HCV genotypesHeiner Wedemeyer
Journal of Hepatology|March 26, 2010
Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDVHeiner Wedemeyer
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Hepatitis D revivalHeiner Wedemeyer
Nature Reviews. Gastroenterology & Hepatology|January 9, 2013
Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?Heiner Wedemeyer
Pflege Zeitschrift|April 4, 2003
[Virus hepatitis: prevalence disease with many manifestations]Heiner Wedemeyer
Deutsche Medizinische Wochenschrift (1946)|June 1, 2017
[Hepatitis E - More than a Rare Travel-Associated Infectious Disease!]Heiner Wedemeyer
Journal of Hepatology|December 1, 2010
From volcano clouds to iLivers: EASL growing in times of changeHeiner Wedemeyer
Pageof 77

Showing results (1-10 of 770) with videos related to

Sort By:
Pageof 77
Journal of Hepatology|November 14, 2009
EASL transitioning into the new decadeHeiner Wedemeyer
Transplantation|March 22, 2018
E-xchange: Hepatitis E and the Risk of Plasma Products for Organ Transplant RecipientsHeiner Wedemeyer
Journal of Hepatology|July 21, 2020
The burden of hepatitis D - defogging the epidemiological horizonHeiner Wedemeyer
Lancet (London, England)|April 4, 2015
Towards interferon-free treatment for all HCV genotypesHeiner Wedemeyer
Journal of Hepatology|March 26, 2010
Re-emerging interest in hepatitis delta: new insights into the dynamic interplay between HBV and HDVHeiner Wedemeyer
Liver International : Official Journal of the International Association for the Study of the Liver|January 6, 2011
Hepatitis D revivalHeiner Wedemeyer
Nature Reviews. Gastroenterology & Hepatology|January 9, 2013
Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?Heiner Wedemeyer
Pflege Zeitschrift|April 4, 2003
[Virus hepatitis: prevalence disease with many manifestations]Heiner Wedemeyer
Deutsche Medizinische Wochenschrift (1946)|June 1, 2017
[Hepatitis E - More than a Rare Travel-Associated Infectious Disease!]Heiner Wedemeyer
Journal of Hepatology|December 1, 2010
From volcano clouds to iLivers: EASL growing in times of changeHeiner Wedemeyer
Pageof 77